Article metrics

Download PDFPDF

Combined targeting of co-stimulatory (OX40) and co-inhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust anti-tumor immunity

 

Online download statistics by month:

Online download statistics by month: December 2019 to January 2024

AbstractFullPdf
Dec 2019010
Jan 2020031
Feb 2020041
Apr 2020021
May 2020050
Jun 202001940
Jul 2020050
Aug 2020010
Sep 2020090
Oct 2020010
Nov 2020010
Dec 2020041
Jan 2021021
Feb 2021020
Apr 2021020
May 2021020
Jun 2021061
Jul 2021030
Sep 2021020
Oct 2021021
Nov 2021042
Dec 2021060
Jan 2022061
Feb 2022030
Mar 2022032
Apr 2022072
May 20220235
Jun 20220162
Jul 20220102
Aug 2022071
Sep 20220126
Oct 20220133
Nov 20220117
Dec 2022051
Jan 2023023
Feb 20230221
Mar 2023032
Apr 2023010
May 2023011
Jul 2023024
Aug 2023012
Sep 2023020
Oct 2023013
Nov 2023043
Dec 2023052
Jan 2024072
Total042864